Caplin Point Laboratories Ltd.

NSE: CAPLIPOINT | BSE: 524742 | ISIN: INE475E01026 | Industry: Pharmaceuticals
| Falling Comet
1723.0000 -13.00 (-0.75%)
NSE Jan 23, 2026 15:31 PM
Volume: 65,712
 

1723.00
-0.75%
ICICI Securities Limited
The Q3FY21 operational performance was mostly in line with our expectations whereas profitability was below due to lower than expected other income. Revenues grew 20.2% YoY to | 274 crore. EBITDA margins improved 89 bps YoY to 30.6% due to higher gross margins, lower other expenses partly offset by higher staff costs likely due to acquired subsidiaries. Hence, EBITDA grew 23.9% YoY to | 84 crore. However, PAT...
Caplin Point Laborat.. has an average target of 2397.00 from 2 brokers.
More from Caplin Point Laboratories Ltd.
Recommended